Nyrada’s NYX-PCSK9i with Statin Achieves 65% Cholesterol Reduction in Preclinical Study
Nyrada Inc have this morning announced encouraging results from an invivo study of their PCSK9i cholesterol inhibitor combined with Pfizer’s… Read more
Incannex to develop IHL-216A formulation for use in pivotal clinical trials required for product registration
Vectura is a state-of-the-art contract development and manufacturing organisation (CDMO) that specialises in the development and manufacture of inhaled drugs… Read more
Nyrada Extraordinary General Meeting Results
Harvest Executes Formal SPA for U.S. Acquisition
Remote communications innovator Harvest Technology Group Limited (ASX:HTG) (Harvest, Company) is pleased to advise that it has executed a formal… Read more
NYR :Improved Drug Candidate Selected for WRAIR Studies
• New lead drug candidate NYR-BI01 advances to efficacy studies in collaboration with the Walter Reed Army Institute of Research… Read more